Sana Biotechnology, Inc. (SANA): A Bull Case Theory [Yahoo! Finance]
Sana Biotechnology, Inc. (SANA)
Company Research
Source: Yahoo! Finance
Sana Biotechnology, Inc.'s share was trading at $4.00 as of February 9th. Why Impact Biomedical Inc. (IBO) Surged On Thursday? Elena Pavlovich/Shutterstock.com Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. SANA has emerged as a compelling player in the race to cure type 1 diabetes (T1D) with its gene-edited, hypoimmune cell therapy, SC451. Recent developments showed a patient remaining insulin-free for an entire year following a donor-cell transplant—a result never seen before and without reported side effects—validating the underlying technology and capturing headlines. SANA's approach, using CD47+ “invisibility” to protect transplanted cells from the immune system, represents a significant technological advantage over competitors like Vertex Pharmaceuticals (VRTX) and Sernova, whose therapies rely on conventional donor cells and chronic immunosuppression. While Vertex leads in trial progression, SA
Show less
Read more
Impact Snapshot
Event Time:
SANA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SANA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SANA alerts
High impacting Sana Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
SANA
News
- Sana Biotechnology (SANA) had its price target lowered by HC Wainwright from $9.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]Yahoo! Finance
- Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business UpdatesGlobeNewswire
- Sana Biotechnology (SANA) Appoints Industry Veteran Brian Piper as New CFO [Yahoo! Finance]Yahoo! Finance
- Sana Biotechnology to Present at March 2026 Investor Conferences [Yahoo! Finance]Yahoo! Finance
SANA
Earnings
- 8/11/25 - Beat
SANA
Sec Filings
- 3/3/26 - Form S-3ASR
- 3/3/26 - Form 10-K
- 3/3/26 - Form 8-K
- SANA's page on the SEC website